Literature DB >> 22776423

Regional distribution of 5α-reductase type 2 in the adult rat brain: an immunohistochemical analysis.

M Paola Castelli1, Alberto Casti, Angelo Casu, Roberto Frau, Marco Bortolato, Saturnino Spiga, Maria Grazia Ennas.   

Abstract

The enzyme 5α-reductase (5αR) catalyzes the conversion of testosterone and other Δ(4)-3-ketosteroids into their 5α-reduced metabolites. Of the five members of the 5αR family, the type 2 enzyme (5αR2) plays a key role in androgen metabolism, and is abundantly distributed in the urogenital system. Although 5αR2 has been reported to be highly expressed in the brain during early developmental stages, little is currently known on its anatomical and cellular distribution in the adult brain. Thus, the present study was designed to determine the detailed localization of 5αR2 in the adult rat brain, using a highly specific polyclonal antibody against this isoform. Parasagittal and coronal sections revealed 5αR2 immunoreactivity throughout most brain regions, with strong immunolabeling in the layers III and VI of the prefrontal and somatosensory cortex, olfactory bulb, thalamic nuclei, CA3 field of hippocampus, basolateral amygdala and Purkinje cell layer of cerebellum. Lower 5αR2 levels were detected in the hypothalamus and midbrain. Moreover, double labeling fluorescence with confocal laser scanning microscopy (CLSM) revealed that 5αR2 is localized in neurons, but not in glial cells. Specifically, the enzyme was documented in the pyramidal neurons of the cortex by CLSM analysis of simultaneous Golgi-Cox and immunofluorescent staining. Finally, low levels of 5αR2 expression were identified in GABAergic cells across the cortex, hippocampus and striatum. These findings show that, in the adult brain, 5αR2 is distributed in critical regions for behavioral regulation, suggesting that the functional role of this isoform is present throughout the entire lifespan of the individual.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22776423      PMCID: PMC3762250          DOI: 10.1016/j.psyneuen.2012.06.008

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN: 0306-4530            Impact factor:   4.905


  58 in total

1.  Improvement of general symptoms in a chronic psychotic patient treated with finasteride: case report.

Authors:  D Koethe; M Bortolato; D Piomelli; F M Leweke
Journal:  Pharmacopsychiatry       Date:  2008-05       Impact factor: 5.788

2.  Brain 5alpha-reductase: cellular, enzymatic, and molecular perspectives and implications for biological function.

Authors:  E D Lephart
Journal:  Mol Cell Neurosci       Date:  1993-12       Impact factor: 4.314

3.  Immunohistochemical presence of 5 alpha-reductase rat type 1-containing cells in the rat brain.

Authors:  Y Tsuruo; T Miyamoto; H Yokoi; K Kitagawa; S Futaki; K Ishimura
Journal:  Brain Res       Date:  1996-05-25       Impact factor: 3.252

4.  Androgens stimulate the morphological maturation of embryonic hypothalamic aromatase-immunoreactive neurons in the mouse.

Authors:  C Beyer; J B Hutchison
Journal:  Brain Res Dev Brain Res       Date:  1997-01-02

5.  Localization of 5alpha-reductase in the rat main olfactory bulb.

Authors:  Emi Kiyokage; Kazunori Toida; Toshiko Suzuki-Yamamoto; Kazunori Ishimura
Journal:  J Comp Neurol       Date:  2005-12-19       Impact factor: 3.215

6.  Morphine withdrawal-induced morphological changes in the nucleus accumbens.

Authors:  Saturnino Spiga; Maria Cristina Puddu; Milena Pisano; Marco Diana
Journal:  Eur J Neurosci       Date:  2005-11       Impact factor: 3.386

7.  Immunocytochemical distribution of aromatase cytochrome P450 in the rat brain using peptide-generated polyclonal antibodies.

Authors:  M K Sanghera; E R Simpson; M J McPhaul; G Kozlowski; A J Conley; E D Lephart
Journal:  Endocrinology       Date:  1991-12       Impact factor: 4.736

Review 8.  Steroid biosynthesis within the frog brain: a model of neuroendocrine regulation.

Authors:  Jean-Luc Do Rego; Jae Young Seong; Delphine Burel; Van Luu-The; Dan Larhammar; Kazuyoshi Tsutsui; Georges Pelletier; Marie-Christine Tonon; Hubert Vaudry
Journal:  Ann N Y Acad Sci       Date:  2009-04       Impact factor: 5.691

Review 9.  Neurosteroids in the context of stress: implications for depressive disorders.

Authors:  Susan S Girdler; Rebecca Klatzkin
Journal:  Pharmacol Ther       Date:  2007-05-24       Impact factor: 12.310

10.  Adult male rat hippocampus synthesizes estradiol from pregnenolone by cytochromes P45017alpha and P450 aromatase localized in neurons.

Authors:  Yasushi Hojo; Taka-Aki Hattori; Taihei Enami; Aizo Furukawa; Kumiko Suzuki; Hiro-Taka Ishii; Hideo Mukai; John H Morrison; William G M Janssen; Shiro Kominami; Nobuhiro Harada; Tetsuya Kimoto; Suguru Kawato
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-23       Impact factor: 11.205

View more
  25 in total

1.  Allopregnanolone is required for prepulse inhibition deficits induced by D1 dopamine receptor activation.

Authors:  Laura J Mosher; Roberto Cadeddu; Sabrina Yen; Jeffrey L Staudinger; Francesco Traccis; Stephen C Fowler; Jamie L Maguire; Marco Bortolato
Journal:  Psychoneuroendocrinology       Date:  2019-06-14       Impact factor: 4.905

2.  Targeting neurosteroid synthesis as a therapy for schizophrenia-related alterations induced by early psychosocial stress.

Authors:  Roberto Frau; Federico Abbiati; Valentina Bini; Alberto Casti; Donatella Caruso; Paola Devoto; Marco Bortolato
Journal:  Schizophr Res       Date:  2015-05-18       Impact factor: 4.939

3.  The effects of age, sex, and hormones on emotional conflict-related brain response during adolescence.

Authors:  Anita Cservenka; Madison L Stroup; Amit Etkin; Bonnie J Nagel
Journal:  Brain Cogn       Date:  2015-07-11       Impact factor: 2.310

4.  Neurosteroids increase tonic GABAergic inhibition in the lateral section of the central amygdala in mice.

Authors:  H Romo-Parra; P Blaesse; L Sosulina; H-C Pape
Journal:  J Neurophysiol       Date:  2015-03-18       Impact factor: 2.714

5.  The 5α-Reductase Inhibitor Finasteride Exerts Neuroprotection Against Ischemic Brain Injury in Aged Male Rats.

Authors:  Motoki Tanaka; Takunori Ogaeri; Mikhail Samsonov; Masahiro Sokabe
Journal:  Transl Stroke Res       Date:  2018-03-25       Impact factor: 6.829

6.  The Neurosteroidogenic Enzyme 5α-Reductase Mediates Psychotic-Like Complications of Sleep Deprivation.

Authors:  Roberto Frau; Valentina Bini; Alessio Soggiu; Simona Scheggi; Alessandra Pardu; Silvia Fanni; Paola Roncada; Monica Puligheddu; Francesco Marrosu; Donatella Caruso; Paola Devoto; Marco Bortolato
Journal:  Neuropsychopharmacology       Date:  2017-02-15       Impact factor: 7.853

Review 7.  The implication of neuroactive steroids in Tourette's syndrome pathogenesis: A role for 5α-reductase?

Authors:  M Bortolato; R Frau; S C Godar; L J Mosher; S Paba; F Marrosu; P Devoto
Journal:  J Neuroendocrinol       Date:  2013-11       Impact factor: 3.627

8.  Finasteride inhibited brain dopaminergic system and open-field behaviors in adolescent male rats.

Authors:  Li Li; Yun-Xiao Kang; Xiao-Ming Ji; Ying-Kun Li; Shuang-Cheng Li; Xiang-Jian Zhang; Hui-Xian Cui; Ge-Ming Shi
Journal:  CNS Neurosci Ther       Date:  2017-12-06       Impact factor: 5.243

9.  Steroid 5α-reductase 2 deficiency leads to reduced dominance-related and impulse-control behaviors.

Authors:  Laura J Mosher; Sean C Godar; Marc Morissette; Kenneth M McFarlin; Simona Scheggi; Carla Gambarana; Stephen C Fowler; Thérèse Di Paolo; Marco Bortolato
Journal:  Psychoneuroendocrinology       Date:  2018-02-16       Impact factor: 4.905

10.  Steroid 5α-reductase in adult rat brain after neonatal dihydrotestosterone administration.

Authors:  P Sánchez; J M Torres; B Castro; R G Del Moral; J de Dios Luna; E Ortega
Journal:  Neurochem Res       Date:  2012-12-11       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.